Success Story: NIW Approved Without RFE! Our Firm Helped a Specialist Achieve Success
Client’s Testimonial:
"I am deeply grateful for the team’s expertise in handling my NIW petition. They took the time to understand the technical nuances of my work in the molecular biology field, framing its significance to U.S. biomedical research with great precision. Receiving an approval without an RFE is a testament to their thorough and professional approach. I highly recommend them to any researcher looking for an attorney team that values scientific rigor.”
On April 30th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Specialist in the Field of Optical Microscopy (Approval Notice).
General Field: Optical Microscopy
Position at the Time of Case Filing: Specialist
Country of Origin: Canada
State of Residence at the Time of Filing: Vermont
Approval Notice Date: April 30th, 2026
Processing Time: 22 months, 5 days (Premium Processing Upgrade Requested)
Case Summary:
Advancing disease research often depends on seeing biological structures that conventional imaging tools cannot clearly reveal. This was the central focus of the client’s I-140 NIW petition, which presented the client as an expert in optical microscopy whose proposed endeavor is to continue developing a cutting-edge super-resolution imaging approach for revealing nanoscale ultrastructures within tissues and cells.
The client holds an M.S. in photonics and optoelectronics and is currently conducting research in optical microscopy at a U.S. university research setting. The petition explained that the client’s work can help advance the understanding of molecular biology and enable new insights into disease mechanisms and therapeutic targets. Rather than presenting the research as limited to one laboratory or employer, the petition framed it as work with broader national importance because of its relevance to biomedical imaging, disease diagnosis, and technologies that support U.S. scientific leadership.
The client’s record included several objective indicators of research progress:
- 3 peer-reviewed journal articles, 1 conference paper, and 4 abstracts, including 2 first-authored abstracts
- 34 citations to the client’s published work
- Funding support from the Taiwan Ministry of Science and Technology and the National Institutes of Health
The petition also included 2 letters of recommendation from experts in the field. These letters supported the argument that the client is well-positioned to continue advancing the proposed endeavor and that the client’s research has already influenced important areas of optical microscopy and biomedical imaging. As one expert noted:
“[Client’s] innovative approach, comprehensive findings, and impact on non-invasive diagnostic tools underscore his invaluable contributions to advancing healthcare and his position as a trailblazer in the field.”
This I-140 NIW approval reflects a carefully prepared petition that connected the client’s advanced training, publication record, and expert support to a proposed endeavor with clear national importance. We congratulate the client on this successful approval and wish them continued success in advancing imaging methods for biomedical discovery and disease research in the United States.